FDA Approves OXYCODONE HYDROCHLORIDE ORAL SOLUTION — Aurolife Pharma, LLC
Aurolife Pharma, LLC received FDA approval for its oxycodone hydrochloride oral solution, a development expected to bolster generic competition and potentially improve supply availability within the immediate-release opioid market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day